Research output per year
Research output per year
Search results
-
2023
Access to medicines for rare diseases: A European regulatory roadmap for academia
Rosenberg, N., van den Berg, S., Stolwijk, N. N., Jacobs, B. A. W., Post, H. C., Pasmooij, A. M. G., de Visser, S. J. & Hollak, C. E. M., 2023, In: Frontiers in pharmacology. 14, 1142351.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Development of medicines for rare diseases and inborn errors of metabolism: Toward novel public–private partnerships
Rosenberg, N., Stolwijk, N. N., van den Berg, S., Heus, J. J., van der Wel, V., van Gelder, T., Bosch, A. M., de Visser, S. J. & Hollak, C. E. M., Sept 2023, In: Journal of Inherited Metabolic Disease. 46, 5, p. 806-816 11 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access3 Citations (Scopus) -
2022
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care
Sirks, M. J., van Dijk, E. H. C., Rosenberg, N., Hollak, C. E. M., Aslanis, S., Cheung, C. M. G., Chowers, I., Eandi, C. M., Freund, K. B., Holz, F. G., Kaiser, P. K., Lotery, A. J., Ohno-Matsui, K., Querques, G., Subhi, Y., Tadayoni, R., Wykoff, C. C., Zur, D., Diederen, R. M. H., Boon, C. J. F., & 1 others, 1 Nov 2022, In: Acta ophthalmologica. 100, 7, p. e1522-e1532Research output: Contribution to journal › Article › Academic › peer-review
Open Access43 Citations (Scopus) -
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review
van der Ree, M. H., van Dussen, L., Rosenberg, N., Stolwijk, N., van den Berg, S., van der Wel, V., Jacobs, B. A. W., Wilde, A. A. M., Hollak, C. E. M. & Postema, P. G., 1 Nov 2022, In: EP Europace. 24, 11, p. 1809-1823 15 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access10 Citations (Scopus)